Lunit lends a hand to Sweden’s national cancer screening program

South Korean medical AI company Lunit is helping to increase cancer screening capacity in Sweden by partnering with one of the country’s largest private healthcare providers.

It recently signed a three-year agreement with Capio S:t Göran Hospital to supply and license its AI-powered mammography analysis software Lunit INSIGHT MMG.

According to a press release, the AI ​​tool will allow the hospital to analyze breast images of approximately 78,000 patients each year.


For years there has been a reported shortage of medical professionals and specialists in Sweden, according to the National Board of Health and Welfare. Lunit says its AI solution has the potential to fill this gap while improving the country’s national cancer screening program by improving the accuracy of cancer detection using AI.

Capio S:t Göran’s decision to adopt Lunit INSIGHT MMG was largely informed by a recent study on its application in a medical setting. The software was used to analyze breast image data from more than 55,000 Swedish patients at Capio S:t Göran. The AI ​​tool was shown to achieve higher cancer detection rates and lower recall rates compared to the scan performed by two radiologists.

It is said that the hospital will become the first breast center to use AI as an independent reader of mammograms, which will relieve the excessive amount of readings for radiologists and ensure shorter waiting times for patients.


Lunit recently created its 100% subsidiary European subsidiary in the Netherlands, which inaugurates the expansion of its commercial network and its partnerships. It appeared to want to take a share of the $20 billion market, which was expected to grow to $163 billion in revenue by 2027.

Separately, Lunit announced last week that it is collaborating with the National Cancer Center Hospital East in Japan to evaluate and validate its AI pathology solution for tissue data analysis, Lunit SCOPE.


“This collaboration represents an important step in using AI technology to address the shortage of radiologists in Sweden. Lunit INSIGHT MMG has the potential to revolutionize mammography analysis, make a substantial contribution to the national cancer screening program and ultimately improve patient outcomes as well,” commented Lunit CEO , Brandon Suh.

Post source: Mobi Health

Leave a Comment